GO:0042795 snRNA transcription by RNA polymerase II: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0042795 describes the synthesis of small nuclear RNAs (snRNAs) from a DNA template by RNA polymerase II (Pol II), initiating at a Pol II promoter.
• snRNA transcription by Pol II is distinguished from Pol II mRNA transcription by its use of the SNAPc (snRNA-activating protein complex) for promoter recognition and the Integrator complex for 3' end processing.
• The process is essential for spliceosome biogenesis and function, as U1, U2, U4, and U5 snRNAs are Pol II products, while U6 is typically Pol III-transcribed.
• Structural studies have revealed the molecular architecture of the Pol II-SNAPc pre-initiation complex, providing a framework for understanding promoter specificity.
• Dysregulation of snRNA transcription and processing is linked to developmental disorders and cancers, often through mutations in Integrator subunits or SNAPc components.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable causal dissection of snRNA transcription factors and their roles in disease.
Description
Small nuclear RNAs (snRNAs) are essential components of the spliceosome, the machinery that removes introns from pre-mRNA. The transcription of most spliceosomal snRNAs (U1, U2, U4, U5) is carried out by RNA polymerase II (Pol II) and is annotated by the Gene Ontology term GO:0042795, snRNA transcription by RNA polymerase II. This process is unique among Pol II transcription programs because it relies on a dedicated promoter recognition factor, the snRNA-activating protein complex (SNAPc), and a specialized 3' end processing machinery, the Integrator complex. Understanding GO:0042795 is therefore critical for dissecting the biogenesis of the spliceosome and its impact on gene expression. Researchers study snRNA transcription by Pol II to uncover mechanisms of promoter specificity, transcription elongation control, and RNA processing, as well as to link defects in these pathways to human diseases such as cancer and neurodevelopmental disorders. The term encompasses the entire biosynthetic process, from initiation at the Pol II promoter to the production of mature snRNA, and is distinct from Pol III-dependent snRNA transcription (e.g., U6).
snRNA transcription by RNA polymerase II At A Glance
| GO ID | GO:0042795 |
|---|---|
| GO term | snRNA transcription by RNA polymerase II |
| Ontology | biological_process |
| Synonym | snRNA transcription from Pol II promoter; snRNA transcription from RNA polymerase II promoter |
| Major function | Synthesis of spliceosomal snRNAs (e.g., U1, U2, U4, U5) by Pol II, essential for spliceosome assembly and pre-mRNA splicing. |
| Key factors | SNAPc (snRNA-activating protein complex), Pol II, Integrator complex, and general transcription factors. |
| Distinguishing feature | Use of SNAPc for promoter recognition and Integrator for 3' end processing, unlike mRNA transcription. |
| Cellular location | Nucleus |
| Related process | Pre-mRNA splicing, spliceosome assembly. |
What Is GO:0042795?
GO:0042795, snRNA transcription by RNA polymerase II, is defined as the synthesis of small nuclear RNA (snRNA) from a DNA template by RNA Polymerase II (Pol II), originating at a Pol II promoter. This process includes promoter recognition by SNAPc, transcription initiation, elongation, and co-transcriptional 3' end processing by the Integrator complex, ultimately yielding functional snRNAs that participate in pre-mRNA splicing.
Why Is snRNA transcription by RNA polymerase II Important in Cell Biology?
snRNA transcription by RNA polymerase II is a cornerstone of gene expression because it supplies the spliceosomal snRNAs required for intron removal from nearly all human pre-mRNAs. Defects in this pathway lead to widespread splicing defects, which are associated with developmental disorders and cancers. Moreover, the unique machinery of snRNA transcription, including SNAPc and Integrator, provides potential therapeutic targets and research tools for understanding transcriptional regulation.
• Provides essential snRNAs (U1, U2, U4, U5) for spliceosome assembly and pre-mRNA splicing.
• Serves as a model for studying Pol II promoter specificity and transcription initiation.
• Involves the Integrator complex, which couples transcription and RNA processing.
• Dysregulation is linked to cancer and neurodevelopmental disorders.
• Offers targets for CRISPR-based functional genomics and drug discovery.
• Highlights differences between Pol II and Pol III snRNA transcription (e.g., U6).
• Contributes to the understanding of co-transcriptional RNA processing.
• Enables investigation of transcription elongation control via phosphatases and regulatory RNAs.
What Happens During snRNA transcription by RNA polymerase II?
Promoter Recognition and Pre-Initiation Complex Assembly
In simple terms: First, a special protein complex called SNAPc recognizes the snRNA gene promoter and recruits RNA polymerase II to start transcription.
snRNA genes transcribed by Pol II possess a unique promoter architecture that lacks a TATA box and relies on the snRNA-activating protein complex (SNAPc) to recognize the proximal sequence element (PSE). Structural studies have revealed how SNAPc binds DNA and recruits Pol II and general transcription factors to form a pre-initiation complex, providing a molecular basis for promoter specificity. This step is a key regulatory checkpoint and distinguishes snRNA transcription from mRNA transcription.
Transcription Initiation and Elongation
In simple terms: Once Pol II is recruited, it starts synthesizing the snRNA and moves along the DNA, but its progression is tightly controlled.
Following initiation, Pol II transitions to productive elongation, a process regulated by phosphorylation of the C-terminal domain and by factors such as the phosphatase PP1, which promotes pause release. Elongation is also influenced by regulatory RNAs and their modifications; for example, pseudouridylation of 7SK RNA by PUS7 regulates Pol II elongation. These mechanisms ensure proper synthesis of snRNAs and coordinate transcription with downstream processing.
3' End Processing by the Integrator Complex
In simple terms: At the end of the snRNA gene, a large machine called Integrator cuts the RNA to create the correct end, which is different from how messenger RNAs are ended.
The Integrator complex is a multi-subunit machinery that associates with Pol II and catalyzes endonucleolytic cleavage of nascent snRNA transcripts, a step essential for snRNA maturation. This co-transcriptional processing is unique to snRNA genes and is coupled to transcription termination. Integrator also plays roles in other non-coding RNA processing and gene regulation, highlighting its multitasking nature.
Termination and Release
In simple terms: After the RNA is cut, transcription stops and the polymerase is released from the DNA.
Termination of snRNA transcription by Pol II involves DNA-directed termination mechanisms that are distinct from polyadenylation-dependent termination of mRNAs. Recent studies have elucidated how Pol II is released from snRNA genes, ensuring efficient recycling and preventing read-through into neighboring genes. This step completes the transcription cycle and allows the mature snRNA to engage with assembly factors.
Key Genes Involved in GO:0042795 snRNA transcription by RNA polymerase II
The following genes encode core components and regulators of snRNA transcription by RNA polymerase II, as supported by structural and functional studies.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SNAPC1 | Subunit of SNAPc, binds PSE | Essential for snRNA promoter recognition; knockout impairs snRNA transcription. |
| SNAPC2 | Subunit of SNAPc | Required for SNAPc assembly and DNA binding. |
| SNAPC3 | Subunit of SNAPc | Facilitates Pol II recruitment. |
| SNAPC4 | Subunit of SNAPc | Contains DNA-binding domain; key for promoter specificity. |
| SNAPC5 | Subunit of SNAPc | Stabilizes SNAPc complex. |
| POLR2A | Largest subunit of Pol II | Catalytic core; target for transcription inhibitors. |
| POLR2B | Second largest subunit of Pol II | Part of active site; mutations affect elongation. |
| INTS1 | Integrator subunit | Required for snRNA 3' end processing. |
| INTS2 | Integrator subunit | Involved in cleavage and termination. |
| INTS3 | Integrator subunit | Scaffold for Integrator assembly. |
| INTS4 | Integrator subunit | Essential for Integrator function. |
| INTS5 | Integrator subunit | Regulates phosphatase activity. |
| INTS6 | Integrator subunit | Links transcription and processing. |
| INTS7 | Integrator subunit | Required for snRNA maturation. |
| INTS8 | Integrator subunit | Part of cleavage module. |
| INTS9 | Integrator subunit | Interacts with Pol II CTD. |
| INTS10 | Integrator subunit | Involved in termination. |
| INTS11 | Integrator subunit | Catalytic subunit for RNA cleavage. |
| INTS12 | Integrator subunit | Regulatory role. |
| INTS13 | Integrator subunit | Modulates Integrator activity. |
| INTS14 | Integrator subunit | Required for snRNA processing. |
How Is snRNA transcription by RNA polymerase II Regulated?
snRNA transcription by Pol II is regulated at multiple levels. Promoter recognition by SNAPc is a key step and can be modulated by cellular signals. Elongation is controlled by phosphorylation of the Pol II C-terminal domain, with phosphatases such as PP1 promoting pause release. Additionally, regulatory RNAs like 7SK and their post-transcriptional modifications (e.g., pseudouridylation by PUS7) influence Pol II elongation. The Integrator complex itself is subject to regulation, and its activity couples transcription with 3' end processing. These layers of regulation ensure appropriate snRNA levels in response to cellular demands.
snRNA transcription by RNA polymerase II and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| INTS1 | Neurodevelopmental disorder | Knockout in neuronal cell lines or organoids |
| INTS11 | Cancer, splicing defects | Point mutation knock-in to mimic patient mutations |
| SNAPC4 | Developmental defects | Knockout in stem cells followed by differentiation |
| POLR2A | Cancer, transcription addiction | Overexpression or point mutation to study drug resistance |
| PUS7 | Neurological disorders | Knockout to assess 7SK pseudouridylation and Pol II elongation |
Cancer
Dysregulation of snRNA transcription and Integrator function has been observed in various cancers. Mutations in Integrator subunits can lead to aberrant snRNA processing and altered gene expression, contributing to tumorigenesis. Targeting the snRNA transcription machinery is being explored as a therapeutic strategy.
Neurodevelopmental Disorders
Mutations in genes encoding SNAPc or Integrator components have been linked to neurodevelopmental disorders, likely due to defective snRNA biogenesis and subsequent splicing defects. These findings highlight the importance of snRNA transcription in normal development.
Splicing-Related Diseases
Because snRNAs are core components of the spliceosome, defects in their transcription can cause widespread splicing abnormalities associated with diseases such as retinitis pigmentosa and spinal muscular atrophy. Understanding snRNA transcription provides insight into these splicing-related pathologies.
From snRNA transcription by RNA polymerase II-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does SNAPc subunit X directly regulate snRNA transcription? | Knockout cell line (e.g., HEK293) followed by snRNA qPCR |
| What is the effect of a patient-derived point mutation in INTS11? | Point mutation knock-in via CRISPR |
| How does tagging Pol II affect its interaction with SNAPc? | Tagged knock-in of POLR2A with GFP or FLAG |
| Can overexpression of SNAPC4 rescue snRNA transcription defects? | Overexpression cell line |
| What is the genome-wide binding profile of SNAPc? | Knock-in of tagged SNAPC1 for ChIP-seq |
| Does loss of Integrator affect splicing efficiency? | Knockout of INTS subunits followed by RNA-seq |
How to Study the snRNA transcription by RNA polymerase II Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | snRNA levels and splicing patterns | Assessing effects of gene knockout on snRNA biogenesis |
| ChIP-seq | Binding of Pol II, SNAPc, Integrator to DNA | Mapping promoter occupancy and elongation |
| Cryo-EM | 3D structure of transcription complexes | Understanding SNAPc-dependent initiation |
| CRISPR screen | Genes required for snRNA transcription | Identifying novel regulators |
| qRT-PCR | Relative snRNA expression | Validating knockout or overexpression |
| Western blot | Protein levels of SNAPc/Integrator subunits | Confirming knockout efficiency |
| Immunoprecipitation | Protein-protein interactions | Studying SNAPc-Pol II assembly |
| Nascent RNA labeling | Transcription rate | Measuring elongation dynamics |
RNA-seq and snRNA Quantification
RNA sequencing can quantify snRNA levels and detect splicing changes upon perturbation of snRNA transcription factors. This method is widely used to assess the impact of knockout or knockdown of SNAPc and Integrator subunits.
ChIP-seq and ChIP-qPCR
Chromatin immunoprecipitation followed by sequencing (ChIP-seq) allows mapping of Pol II, SNAPc, and Integrator binding across the genome, revealing promoter occupancy and elongation dynamics at snRNA genes.
Structural Biology (Cryo-EM)
Cryo-electron microscopy has been used to solve the structure of the Pol II-SNAPc pre-initiation complex, providing mechanistic insights into promoter recognition and transcription initiation.
CRISPR Screens
Genome-wide CRISPR knockout screens can identify genes required for snRNA transcription and processing, uncovering novel regulators and potential drug targets.
How CRISPR Can Be Used to Study GO:0042795 snRNA transcription by RNA polymerase II
Knockout
CRISPR knockout of SNAPc or Integrator subunits in cell lines (e.g., HEK293, HeLa) can abolish snRNA transcription, leading to splicing defects and cell growth arrest. These models are used to study the essentiality of individual subunits and to identify compensatory pathways.
Point Mutation
Introducing patient-derived point mutations into genes such as INTS11 or POLR2A via CRISPR allows researchers to dissect the molecular consequences of specific amino acid changes on snRNA transcription and processing.
Knock-in
Tagged knock-in of SNAPc subunits (e.g., GFP or FLAG) enables live-cell imaging and proteomic analysis of the snRNA transcription machinery, providing insights into its dynamics and interactions.
Overexpression
CRISPR-mediated overexpression of SNAPc components or Pol II subunits can rescue loss-of-function phenotypes or amplify snRNA transcription, useful for biochemical purification and structural studies.
How EDITGENE Supports snRNA transcription by RNA polymerase II Research
Researchers studying snRNA transcription by RNA polymerase II-related genes often need to determine whether a candidate gene is causally involved in snRNA biogenesis, splicing, or disease. EDITGENE provides a comprehensive suite of CRISPR services to generate precisely engineered cell models, enabling rigorous functional validation.
Contact EDITGENE today to design your custom CRISPR model for snRNA transcription by RNA polymerase II research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| ELL2 Knockout HEK293 Cell Line | EDJ-KQ7752 | Human | 22936 | Details Get a Quote |
| ICE1 Knockout HEK293 Cell Line | EDJ-KQ7995 | Human | 23379 | Details Get a Quote |
| ICE2 Knockout HEK293 Cell Line | EDJ-KQ13797 | Human | 79664 | Details Get a Quote |
| ELL2 Knockout A-549 Cell Line | EDJ-KQ33191 | Human | 22936 | Details Get a Quote |
| ELL2 Knockout HCT 116 Cell Line | EDJ-KQ33192 | Human | 22936 | Details Get a Quote |
| ELL2 Knockout HeLa Cell Line | EDJ-KQ33193 | Human | 22936 | Details Get a Quote |
| ICE1 Knockout A-549 Cell Line | EDJ-KQ33729 | Human | 23379 | Details Get a Quote |
| ICE1 Knockout HCT 116 Cell Line | EDJ-KQ33730 | Human | 23379 | Details Get a Quote |
| ICE1 Knockout HeLa Cell Line | EDJ-KQ33731 | Human | 23379 | Details Get a Quote |
| ICE2 Knockout HCT 116 Cell Line | EDJ-KQ43592 | Human | 79664 | Details Get a Quote |
| ICE2 Knockout HeLa Cell Line | EDJ-KQ43593 | Human | 79664 | Details Get a Quote |
| SNAPC5 Knockout HEK293 Cell Line | EDJ-KQ50954 | Human | 10302 | Details Get a Quote |
| ELL3 Knockout HEK293 Cell Line | EDJ-KQ51738 | Human | 80237 | Details Get a Quote |
| SNAPC5 Knockout HeLa Cell Line | EDJ-KQ55371 | Human | 10302 | Details Get a Quote |
| ELL3 Knockout HeLa Cell Line | EDJ-KQ57314 | Human | 80237 | Details Get a Quote |
Frequently Asked Questions About snRNA transcription by RNA polymerase II
What is snRNA transcription by RNA polymerase II?
It is the process of synthesizing small nuclear RNAs (snRNAs) from a DNA template using RNA polymerase II, as defined by GO:0042795.
What genes are involved in snRNA transcription by RNA polymerase II?
Key genes include SNAPC1-5, POLR2A, and Integrator subunits (INTS1-14), which are essential for promoter recognition, transcription, and 3' end processing.
How is snRNA transcription by Pol II different from mRNA transcription?
snRNA transcription uses SNAPc for promoter recognition and the Integrator complex for 3' end processing, unlike mRNA transcription which relies on TATA-binding protein and polyadenylation.
Which snRNAs are transcribed by RNA polymerase II?
U1, U2, U4, and U5 snRNAs are transcribed by Pol II, while U6 is typically transcribed by Pol III.
What is the role of the Integrator complex in snRNA transcription?
The Integrator complex catalyzes the endonucleolytic cleavage of nascent snRNA transcripts, a critical step for their maturation and termination.
How can CRISPR be used to study snRNA transcription?
CRISPR knockout, point mutation, knock-in, and overexpression models allow functional dissection of genes involved in snRNA transcription and their roles in disease.
What diseases are associated with defects in snRNA transcription?
Defects have been linked to cancer, neurodevelopmental disorders, and splicing-related diseases such as retinitis pigmentosa.
What methods are used to study snRNA transcription by Pol II?
Common methods include RNA-seq, ChIP-seq, cryo-EM, and CRISPR screens.
Is SNAPc required for all Pol II transcription?
No, SNAPc is specifically required for snRNA gene transcription by Pol II, not for mRNA genes.
What is the role of PP1 in snRNA transcription?
PP1 promotes RNA polymerase II pause release, thereby sustaining global transcription including snRNA genes.
Conclusion
GO:0042795, snRNA transcription by RNA polymerase II, is a specialized transcriptional program essential for spliceosome function and gene expression. Its unique machinery, including SNAPc and the Integrator complex, offers rich opportunities for mechanistic and disease-focused research. CRISPR-based models and advanced sequencing methods are invaluable for dissecting this pathway and its links to human disorders.
References
- 1. Wang Z et al.. 2024. The phosphatase PP1 sustains global transcription by promoting RNA polymerase II pause release.. Mol Cell 84(24):4824-4842.e7 PMID: 39603240
- 2. Girbig M et al.. 2022. Structural insights into nuclear transcription by eukaryotic DNA-dependent RNA polymerases.. Nat Rev Mol Cell Biol 23(9):603-622 PMID: 35505252
- 3. Carrocci TJ et al.. 2024. Emerging and re-emerging themes in co-transcriptional pre-mRNA splicing.. Mol Cell 84(19):3656-3666 PMID: 39366353
- 4. Lipinski KA et al.. 2022. Yeast U6 snRNA made by RNA polymerase II is less stable but functional.. RNA 28(12):1606-1620 PMID: 36195346
- 5. Rengachari S et al.. 2022. Structural basis of SNAPc-dependent snRNA transcription initiation by RNA polymerase II.. Nat Struct Mol Biol 29(12):1159-1169 PMID: 36424526
- 6. Davidson L et al.. 2024. DNA-directed termination of mammalian RNA polymerase II.. Genes Dev 38(21-24):998-1019 PMID: 39496457
- 7. Welsh SA et al.. 2023. Genomic regulation of transcription and RNA processing by the multitasking Integrator complex.. Nat Rev Mol Cell Biol 24(3):204-220 PMID: 36180603
- 8. Zhao Y et al.. 2025. Pseudouridylation of 7SK by PUS7 regulates Pol II transcription elongation.. Nat Commun 16(1):9595 PMID: 41168165
